Octreotide With or Without Prednisone in Treating Patients With Metastatic or Recurrent Thymoma
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die.
PURPOSE: Phase II trial to compare the effectiveness of octreotide alone or with prednisone
in treating patients with metastatic or recurrent thymoma.